192 related articles for article (PubMed ID: 16731534)
1. Erythropoietin improves myocardial performance in doxorubicin-induced cardiomyopathy.
Hamed S; Barshack I; Luboshits G; Wexler D; Deutsch V; Keren G; George J
Eur Heart J; 2006 Aug; 27(15):1876-83. PubMed ID: 16731534
[TBL] [Abstract][Full Text] [Related]
2. Erythropoietin promotes endothelial progenitor cell proliferative and adhesive properties in a PI 3-kinase-dependent manner.
George J; Goldstein E; Abashidze A; Wexler D; Hamed S; Shmilovich H; Deutsch V; Miller H; Keren G; Roth A
Cardiovasc Res; 2005 Nov; 68(2):299-306. PubMed ID: 16048724
[TBL] [Abstract][Full Text] [Related]
3. Preventive cardioprotection of erythropoietin against doxorubicin-induced cardiomyopathy.
Chen X; Chen Y; Bi Y; Fu N; Shan C; Wang S; Aslam S; Wang PW; Xu J
Cardiovasc Drugs Ther; 2007 Oct; 21(5):367-74. PubMed ID: 17924179
[TBL] [Abstract][Full Text] [Related]
4. The influence of the time interval between monoHER and doxorubicin administration on the protection against doxorubicin-induced cardiotoxicity in mice.
Bruynzeel AM; Mul PP; Berkhof J; Bast A; Niessen HW; van der Vijgh WJ
Cancer Chemother Pharmacol; 2006 Nov; 58(5):699-702. PubMed ID: 16565833
[TBL] [Abstract][Full Text] [Related]
5. Protection against doxorubicin cardiomyopathy in rats: role of phosphodiesterase inhibitors type 4.
Mohamed HE; Asker ME; Ali SI; el-Fattah TM
J Pharm Pharmacol; 2004 Jun; 56(6):757-68. PubMed ID: 15231041
[TBL] [Abstract][Full Text] [Related]
6. Cardiotoxicity of doxorubicin/paclitaxel combination in rats: effect of sequence and timing of administration.
Saad SY; Najjar TA; Alashari M
J Biochem Mol Toxicol; 2004; 18(2):78-86. PubMed ID: 15122649
[TBL] [Abstract][Full Text] [Related]
7. Differential effects of organic nitrates on endothelial progenitor cells are determined by oxidative stress.
Thum T; Fraccarollo D; Thum S; Schultheiss M; Daiber A; Wenzel P; Munzel T; Ertl G; Bauersachs J
Arterioscler Thromb Vasc Biol; 2007 Apr; 27(4):748-54. PubMed ID: 17255540
[TBL] [Abstract][Full Text] [Related]
8. Dose-response relationship of dexrazoxane for prevention of doxorubicin-induced cardiotoxicity in mice, rats, and dogs.
Imondi AR; Della Torre P; Mazué G; Sullivan TM; Robbins TL; Hagerman LM; Podestà A; Pinciroli G
Cancer Res; 1996 Sep; 56(18):4200-4. PubMed ID: 8797592
[TBL] [Abstract][Full Text] [Related]
9. Endothelial nitric oxide synthase uncoupling impairs endothelial progenitor cell mobilization and function in diabetes.
Thum T; Fraccarollo D; Schultheiss M; Froese S; Galuppo P; Widder JD; Tsikas D; Ertl G; Bauersachs J
Diabetes; 2007 Mar; 56(3):666-74. PubMed ID: 17327434
[TBL] [Abstract][Full Text] [Related]
10. Erythropoietin protects against doxorubicin-induced cardiomyopathy via a phosphatidylinositol 3-kinase-dependent pathway.
Kim KH; Oudit GY; Backx PH
J Pharmacol Exp Ther; 2008 Jan; 324(1):160-9. PubMed ID: 17928571
[TBL] [Abstract][Full Text] [Related]
11. Exercise preconditioning protects against doxorubicin-induced cardiac dysfunction.
Hydock DS; Lien CY; Schneider CM; Hayward R
Med Sci Sports Exerc; 2008 May; 40(5):808-17. PubMed ID: 18408619
[TBL] [Abstract][Full Text] [Related]
12. Transfer of endothelial progenitor cells improves myocardial performance in rats with dilated cardiomyopathy induced following experimental myocarditis.
Werner L; Deutsch V; Barshack I; Miller H; Keren G; George J
J Mol Cell Cardiol; 2005 Oct; 39(4):691-7. PubMed ID: 16125196
[TBL] [Abstract][Full Text] [Related]
13. Effects of the antioxidative beta-blocker celiprolol on endothelial progenitor cells in hypertensive rats.
Yao EH; Fukuda N; Matsumoto T; Katakawa M; Yamamoto C; Han Y; Ueno T; Kobayashi N; Matsumoto K
Am J Hypertens; 2008 Sep; 21(9):1062-8. PubMed ID: 18636069
[TBL] [Abstract][Full Text] [Related]
14. Dexrazoxane protects against doxorubicin-induced cardiomyopathy: upregulation of Akt and Erk phosphorylation in a rat model.
Xiang P; Deng HY; Li K; Huang GY; Chen Y; Tu L; Ng PC; Pong NH; Zhao H; Zhang L; Sung RY
Cancer Chemother Pharmacol; 2009 Jan; 63(2):343-9. PubMed ID: 18379782
[TBL] [Abstract][Full Text] [Related]
15. Erythropoietin improves cardiac function through endothelial progenitor cell and vascular endothelial growth factor mediated neovascularization.
Westenbrink BD; Lipsic E; van der Meer P; van der Harst P; Oeseburg H; Du Marchie Sarvaas GJ; Koster J; Voors AA; van Veldhuisen DJ; van Gilst WH; Schoemaker RG
Eur Heart J; 2007 Aug; 28(16):2018-27. PubMed ID: 17576662
[TBL] [Abstract][Full Text] [Related]
16. How to protect doxorubicin-induced cardiomyopathy in male albino rats?
Shaker O; Sourour DA
J Cardiovasc Pharmacol; 2010 Mar; 55(3):262-8. PubMed ID: 20051877
[TBL] [Abstract][Full Text] [Related]
17. Absence of thrombospondin-2 increases cardiomyocyte damage and matrix disruption in doxorubicin-induced cardiomyopathy.
van Almen GC; Swinnen M; Carai P; Verhesen W; Cleutjens JP; D'hooge J; Verheyen FK; Pinto YM; Schroen B; Carmeliet P; Heymans S
J Mol Cell Cardiol; 2011 Sep; 51(3):318-28. PubMed ID: 21624372
[TBL] [Abstract][Full Text] [Related]
18. Erythropoietin modulates imbalance of matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 in doxorubicin-induced cardiotoxicity.
Chen X; Guo Z; Wang P; Xu M
Heart Lung Circ; 2014 Aug; 23(8):772-7. PubMed ID: 24685074
[TBL] [Abstract][Full Text] [Related]
19. New aspects in probucol cardioprotection against doxorubicin-induced cardiotoxicity.
El-Demerdash E; Ali AA; Sayed-Ahmed MM; Osman AM
Cancer Chemother Pharmacol; 2003 Nov; 52(5):411-6. PubMed ID: 12879278
[TBL] [Abstract][Full Text] [Related]
20. Morphine is protective against doxorubicin-induced cardiotoxicity in rat.
Kelishomi RB; Ejtemaeemehr S; Tavangar SM; Rahimian R; Mobarakeh JI; Dehpour AR
Toxicology; 2008 Jan; 243(1-2):96-104. PubMed ID: 17988779
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
